The global multiple sclerosis therapies market size was valued at US$ 26.9 billion in 2023. IMARC Group projects that the market will expand to US$ 37.8 billion by 2032, reflecting a compound annual growth rate (CAGR) of 3.7% from 2024 to 2032. https://www.imarcgroup.com/multiple-sclerosis-therapies-market